miRNA Regulation Network Analysis in Qianliening Capsule Treatment of Benign Prostatic Hyperplasia

Objective. The objective of this study was to evaluate the molecular mechanism by which Qianliening capsule (QC) treats benign prostatic hyperplasia (BPH). Methods. Benign prostatic hyperplasia epithelial cell line BPH-1 was treated with 0, 1.25, 2.5, and 5 mg/mL QC for 48 h, respectively. Evaluatio...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Evid Based Complement Alternat Med
Hlavní autoři: Liu, Liya, Wan, Yun, Shen, Aling, Zhao, Jinyan, Lin, Jiumao, Zhong, Xiaoyong, Zhang, Yuchen, Hong, Zhenfeng
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2015
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4534592/
https://ncbi.nlm.nih.gov/pubmed/26294924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/365484
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky